Status:
COMPLETED
Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Lichen Planus, Oral
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oral lichen planus (OLP) is a chronic inflammatory and relapsing. The average prevalence is 1 to 4%. The clinics forms are many and symptoms are varied. The erosive form, painful and debilitating is c...
Eligibility Criteria
Inclusion
- Patient ≥ 18 years
- Clinical and/or histological diagnosis of erosive or atrophic OLP
- No signs of severe dysplasia at the sampling
Exclusion
- o immunosuppressive or anti-inflammatory therapies at the inclusion
Key Trial Info
Start Date :
March 30 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2016
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT02276573
Start Date
March 30 2015
End Date
March 10 2016
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital saint Roch
Nice, France, 06000